DJIA 17,810.06 91.06 0.51%
NASDAQ 4,712.97 11.10 0.24%
S&P 500 2,063.50 10.75 0.52%
market minute promo

Antares Pharma, Inc. (NASDAQ: ATRS)

2.24 -0.05 (-2.18%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ATRS $2.24 -2.18%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.33
Previous Close $2.29
Daily Range $2.23 - $2.34
52-Week Range $1.82 - $5.01
Market Cap $295.0M
P/E Ratio -9.96
Dividend (Yield) $0.00 (0.0%)
Volume 692,759
Average Daily Volume 866,255
Current FY EPS -$0.24

Sector

Healthcare

Industry

Healthcare Information Services

Antares Pharma, Inc. (ATRS) Description

The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral fast melting tablets and reusable needle-free and disposable mini-needle injector systems. Website: http://www.antarespharma.com/

News & Commentary

3 Stocks Crushed by the Market This Week

Find out which health-care stocks got beaten down the most by the market over the past few days.

Analyzing Antares Pharma Q3 2014 Earnings

Antares Pharma's (ATRS) CEO Eamonn Hobbs on Q3 2014 Results -- Earnings Call Transcript

Update: Antares Pharma Looks To Improve Intellectual Property

Comparative Analysis Reveals Undervalued Asset In Antares' Pipeline: First And Only Testosterone Aut

Comparative Analysis Reveals Undervalued Asset In Antares' Pipeline: First And Only Testosterone Auto-Injector

Unilife: A Medical Device Company Poised For Major Upside On New Revenue Streams

Antares Pharma: Significant Value Or Value Trap?

Antares: An Analysis Of FDA Briefing Documents For September 17th Advisory Committee Meeting On Test

Antares: An Analysis Of FDA Briefing Documents For September 17th Advisory Committee Meeting On Testosterone Replacement Products

5 Breakout Stocks Under $10 Set to Soar

Antares Pharma's (ATRS) CEO Paul Wotton on Q2 2014 Results - Earnings Call Transcript

Antares: Uncertainty Creates An Exceptional Buying Opportunity

See More ATRS News...

ATRS's Top Competitors

ATRS $2.24 (-2.18%)
Current stock: ATRS
$0.00 (0.00%)
Current stock:
MDT $72.49 (0.57%)
Current stock: MDT
COV $98.44 (0.54%)
Current stock: COV